Pure red cell aplasia following pernicious anemia

Am J Hematol. 1990 Feb;33(2):148-50. doi: 10.1002/ajh.2830330215.

Abstract

A rare case of pure red cell aplasia (PRCA) in association with pernicious anemia is reported. A 40-year-old man presented with typical clinical and laboratory features of pernicious anemia and received intramuscular injections of vitamin B12, with satisfactory response. Anemia recurred 6 months later despite continued therapy, and the patient was noted to have PRCA, which was treated successfully with two courses of high-dose bolus methylprednisolone therapy. His peripheral mononuclear cells before the therapy suppressed colony formation of early erythroid precursors (BFU-E) from normal bone marrow; such a suppressive effect was not found after recovery from anemia.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anemia, Pernicious / complications*
  • Anemia, Pernicious / drug therapy
  • Blood Cell Count
  • Erythroid Precursor Cells / drug effects
  • Erythroid Precursor Cells / pathology
  • Humans
  • Male
  • Methylprednisolone / therapeutic use
  • Red-Cell Aplasia, Pure / blood
  • Red-Cell Aplasia, Pure / complications*
  • Red-Cell Aplasia, Pure / drug therapy
  • Vitamin B 12 / blood
  • Vitamin B 12 / therapeutic use

Substances

  • Vitamin B 12
  • Methylprednisolone